AVBH vs CRL · P/E 12, rev $145.8M vs rev $2.00B
Avidbank Holdings Inc (AVBH) versus Charles River Laboratories (CRL) — a side-by-side from cached financials, not a winner call.
Avidbank Holdings Inc (AVBH) is a banks - regional company listed on US.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Latest reported AVBH revenue for 2025-12-31 was $145.8M. Net income was -$19.6M. Revenue was up 2.3% from 2024-12-31 to 2025-12-31. AVBH currently screens at market cap $164.9M and trailing P/E 12.1.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
AVBH currently screens at market cap $164.9M and trailing P/E 12.1. CRL currently screens at market cap $7.78B.
Not investment advice. Open the AVBH and CRL stock pages for the full models.
Not investment advice.